![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/kristin_headshot.jpg?itok=CZ9oMfGD&c=7d690f04f24a1156b3d9d3982d3bbc68)
Kristin Bennett
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/vishwa_headshot.jpg?itok=s9p1hGgM&c=4b0f2c0a93ef199e2cdd144958827fed)
Vishwa Kolla
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/rashid_attar.jpeg?itok=rzkkcWSu&c=1469a91dfe921bb4e875663f09d80bd6)
Rashid Attar
Rashid Attar joined Qualcomm, San Deigo, CA, USA, and has involved in various aspects CDMA wireless data (EV-DO) and voice systems (IS-95, 1x-Advanced) in 1996, where he was the Project Engineer of CDMA2000-advanced from 2009 to 2013 and CDMA Modem Systems Lead at QCT from 20 through 2013. From 2014 to mid-2016, he led the ultra-low-power ASIC platform project. He is currently a Vice President Engineering with Corporate Research and Development, Qualcomm. He leads the ASIC and Hardware Department in Qualcomm Research. The Qualcomm Research portfolio consists of Communications (5G, Cellular V2X, Satellite Communications, Wi-Fi, and Industrial Internet of Things), ASIC and HW Research and Development, and Embedded IoE systems (Always on computer vision, Autonomous Driving, Robotics, and AR/VR). The ASIC and Hardware Group Research and Development portfolio consists of 5G (RFICs, PAs, Interfaces, Packaging), processors (CPUs, Programmable deep learning accelerators), ultra-low-power platform (processor, communications, memory, machine learning accelerators, power management, wireless charging), core CMOS Research and Development (3-DIC and Thermal-aware designs), and Antenna Design. He holds approximately 160 granted U.S. patents
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/paul_inman.jpg?itok=_JxfOdmA&c=fca690c28f3148226ba10bf3df52390c)
Paul Inman
With more than 25 years' experience of litigating intellectual property (IP) disputes both within the UK and internationally, Paul Inman works with companies ranging from small start-ups to major multi-national corporations. He specialises in the life sciences sector, which includes acting on high-profile pharmaceutical patent infringement cases in the UK Patents Court.
Paul provides life science businesses with commercial advice from an international outlook. His specialist experience ideally places him to provide this expertise and client care, with the ultimate aim of delivering well-rounded advice and guidance to ensure the best possible outcome.
As well as litigating in the English courts, he has co-ordinated and advised on IP and regulatory litigation matters across the globe; from all over Europe and the US, to as far afield as Asia, South Africa, Australia and New Zealand.
Successfully guiding clients through the maze of litigation is where Paul's strength lies, having now been involved over 25 years of litigation in cases leading to more than 40 reported judgments. These range from the tribunals of the UK Patent Office up to the House of Lords, European Patent Office and European Court of Justice.
Paul also has a degree in Molecular Biology and Biochemistry and during his professional career has established an outstanding reputation in the market. He is distinguished in the 2023 edition of IAM Patent 1000: The World's Leading Patent Professionals, ranked individually for both IP law and life sciences law in the peer review publication 'Best Lawyers® in the UK' and recognised in several categories within Chambers & Partners UK 2023.
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/valeria_headshot_002.jpeg?itok=tB6VW-0e&c=298b6a182ccd20df1eea6197d03f7cc6)
Valeria Sadovykh
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/headshot_ken_002.jpeg?itok=kU-WJVMS&c=206c6aea3c462fbdcc3b7c28bba6e8ae)